Difference between revisions of "Part:BBa K3332011"
Xiaoyu Wang (Talk | contribs) |
Huangzinuo (Talk | contribs) |
||
Line 4: | Line 4: | ||
The enzyme efficiently catalyzes the reaction of reducing glyoxalic acid and consuming NADPH. His-tag was added to purify the protein. We use K880005 to construct the expression system and to express and to purify the protein. | The enzyme efficiently catalyzes the reaction of reducing glyoxalic acid and consuming NADPH. His-tag was added to purify the protein. We use K880005 to construct the expression system and to express and to purify the protein. | ||
− | ===Biology=== | + | |
− | + | ||
− | + | ===Biology=== | |
+ | |||
+ | GRHPR, a glyoxylate reductase from human liver, can reduce glyoxylic acid when NADPH is used as cofactor. GRHPR converts glyoxylic acid while consuming NADPH. NADPH is a suitable target compound that can be detected by the signal of fluorescence or OD<sub>340</sub>.<ref>Rumsby G, Cregeen D P. Identification and expression of a cDNA for human hydroxypyruvate/glyoxylate reductase[J]. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1999, 1446(3): 383-388.</ref> | ||
+ | |||
+ | |||
+ | <html> | ||
<figure> | <figure> | ||
<img src="https://2020.igem.org/wiki/images/9/92/T--XMU-China--XMU-China_2020-GOX%E9%94%9A%E5%AE%9A.png" width="90%" style="float:center"> | <img src="https://2020.igem.org/wiki/images/9/92/T--XMU-China--XMU-China_2020-GOX%E9%94%9A%E5%AE%9A.png" width="90%" style="float:center"> | ||
Line 15: | Line 20: | ||
</figure> | </figure> | ||
</html> | </html> | ||
− | Fig 1. GRHPR mechanism | + | :Fig 1. GRHPR mechanism |
===Usage=== | ===Usage=== | ||
− | + | By codon optimization and adding a 6His-tag, the sequence suitable for expression in ''E. coli'' was constructed, and we hoped that it could reduce glyoxylic acid in ''E. coli'' to get fluorescence signal in the next processes we design. | |
+ | |||
The coding sequence of target gene was inserted into an expression vectors with <partinfo>BBa_K880005</partinfo>(<partinfo>BBa_J23100</partinfo> & <partinfo>BBa_B0034</partinfo>) to obtain <partinfo>BBa_K3332056</partinfo>. We transformed the constructed plasmid into ''E. coli'' BL21 (DE3) to verify its successful heterologous expression. | The coding sequence of target gene was inserted into an expression vectors with <partinfo>BBa_K880005</partinfo>(<partinfo>BBa_J23100</partinfo> & <partinfo>BBa_B0034</partinfo>) to obtain <partinfo>BBa_K3332056</partinfo>. We transformed the constructed plasmid into ''E. coli'' BL21 (DE3) to verify its successful heterologous expression. | ||
− | + | ||
+ | <html> | ||
<figure> | <figure> | ||
<img src="https://2020.igem.org/wiki/images/2/2e/T--XMU-China--XMU-China_2020-J23100_B0034_grhpr-his-tag_B0015.png" width="90%" style="float:center"> | <img src="https://2020.igem.org/wiki/images/2/2e/T--XMU-China--XMU-China_2020-J23100_B0034_grhpr-his-tag_B0015.png" width="90%" style="float:center"> | ||
Line 29: | Line 36: | ||
</figure> | </figure> | ||
</html> | </html> | ||
− | Fig 2. Gene circuit of GRHPR | + | :Fig 2. Gene circuit of GRHPR |
===Characterization=== | ===Characterization=== | ||
+ | |||
'''1. Identification''' | '''1. Identification''' | ||
After receiving the synthesized DNA, restriction digestion was done to certify that the plasmid was correct, and the experimental results were shown in figure 3. | After receiving the synthesized DNA, restriction digestion was done to certify that the plasmid was correct, and the experimental results were shown in figure 3. | ||
− | + | <html> | |
<figure> | <figure> | ||
<img src="https://2020.igem.org/wiki/images/e/e8/T--XMU-China--07181.png" width="90%" style="float:center"> | <img src="https://2020.igem.org/wiki/images/e/e8/T--XMU-China--07181.png" width="90%" style="float:center"> | ||
Line 48: | Line 56: | ||
We used J23100 promoter to highly express GRHPR-Histag in ''E. coli'' in our composite part <partinfo>BBa_K3332056</partinfo>. Then, we used GE AKTA Prime Plus FPLC System to get purified GRHPR protein. We found an apparent protein peak in AKTA FPLC System and correct purified protein. | We used J23100 promoter to highly express GRHPR-Histag in ''E. coli'' in our composite part <partinfo>BBa_K3332056</partinfo>. Then, we used GE AKTA Prime Plus FPLC System to get purified GRHPR protein. We found an apparent protein peak in AKTA FPLC System and correct purified protein. | ||
Then, our target bands are observed through SDS-PAGE and the result is shown in figure4. | Then, our target bands are observed through SDS-PAGE and the result is shown in figure4. | ||
− | + | <html> | |
<figure> | <figure> | ||
<img src="https://2020.igem.org/wiki/images/b/b1/T--XMU-China--XMU-China_2020-GRHPR_and_GOX.png" width="90%" style="float:center"> | <img src="https://2020.igem.org/wiki/images/b/b1/T--XMU-China--XMU-China_2020-GRHPR_and_GOX.png" width="90%" style="float:center"> | ||
Line 57: | Line 65: | ||
</figure> | </figure> | ||
</html> | </html> | ||
− | Fig 4. SDS-PAGE of purification products of GRHPR-Histag-pSB1C3 | + | :Fig 4. SDS-PAGE of purification products of GRHPR-Histag-pSB1C3 |
'''3. Ability of consuming NADPH''' | '''3. Ability of consuming NADPH''' | ||
We mixed glyoxylic acid solution, NADPH solution and purified GRHPR protein dissolved in Tris-HCl(pH=7.5). Then, we immediately measured OD<sub>340</sub> changes of our samples. And when NADPH is consumed, OD<sub>340</sub> declines. | We mixed glyoxylic acid solution, NADPH solution and purified GRHPR protein dissolved in Tris-HCl(pH=7.5). Then, we immediately measured OD<sub>340</sub> changes of our samples. And when NADPH is consumed, OD<sub>340</sub> declines. | ||
The experimental result is shown on Figure 5. We can see the OD<sub>340</sub> of samples adding GRHPR decrease very quickly while the OD<sub>340</sub> of control stay almost the same. | The experimental result is shown on Figure 5. We can see the OD<sub>340</sub> of samples adding GRHPR decrease very quickly while the OD<sub>340</sub> of control stay almost the same. | ||
− | + | <html> | |
<figure> | <figure> | ||
<img src="https://2020.igem.org/wiki/images/d/d4/T--XMU-China--XMU-China_2020-GRHPR酶活.png" width="90%" style="float:center"> | <img src="https://2020.igem.org/wiki/images/d/d4/T--XMU-China--XMU-China_2020-GRHPR酶活.png" width="90%" style="float:center"> | ||
Line 71: | Line 79: | ||
</figure> | </figure> | ||
</html> | </html> | ||
− | Fig 5. Enzyme activity of GRHPR | + | :Fig 5. Enzyme activity of GRHPR |
'''4. Kinetic parameter determination''' | '''4. Kinetic parameter determination''' | ||
We successfully got OD<sub>340</sub>-Time curves of GRHPR in the presence of NADPH concentration and OD<sub>340</sub>-Time curves of GRHPR in the presence of glyoxylic acid concentration. Then we calculated relevant enzyme activity and drew 1/V-1/[NADPH] and 1/V-1/[glyoxylic acid] curves, from which we can obtain relevant Km and Vmax. | We successfully got OD<sub>340</sub>-Time curves of GRHPR in the presence of NADPH concentration and OD<sub>340</sub>-Time curves of GRHPR in the presence of glyoxylic acid concentration. Then we calculated relevant enzyme activity and drew 1/V-1/[NADPH] and 1/V-1/[glyoxylic acid] curves, from which we can obtain relevant Km and Vmax. | ||
The result is shown in figure 6 and figure 7. | The result is shown in figure 6 and figure 7. | ||
− | + | <html> | |
<figure> | <figure> | ||
<img src="https://2020.igem.org/wiki/images/4/4c/T--XMU-China--XMU-China_2020-GRHPR_动力学参数1-NADPH底物.png" width="90%" style="float:center"> | <img src="https://2020.igem.org/wiki/images/4/4c/T--XMU-China--XMU-China_2020-GRHPR_动力学参数1-NADPH底物.png" width="90%" style="float:center"> | ||
Line 85: | Line 93: | ||
</figure> | </figure> | ||
</html> | </html> | ||
− | Fig 6. 1/V-1/[NADPH] curve of purified GRHPR reacting with NADPH and glyoxylic acid | + | |
− | + | :Fig 6. 1/V-1/[NADPH] curve of purified GRHPR reacting with NADPH and glyoxylic acid | |
+ | |||
+ | <html> | ||
<figure> | <figure> | ||
<img src="https://2020.igem.org/wiki/images/3/3d/T--XMU-China--XMU-China_2020-GRHPR动力学参数-2-glyoxycolic_底物.png"width="90%" style="float:center"> | <img src="https://2020.igem.org/wiki/images/3/3d/T--XMU-China--XMU-China_2020-GRHPR动力学参数-2-glyoxycolic_底物.png"width="90%" style="float:center"> | ||
Line 95: | Line 105: | ||
</figure> | </figure> | ||
</html> | </html> | ||
− | Fig 7. 1/V-1/[glyoxylic acid] curve of purified GRHPR reacting with NADPH and glyoxylic acid | + | :Fig 7. 1/V-1/[glyoxylic acid] curve of purified GRHPR reacting with NADPH and glyoxylic acid |
+ | |||
===References=== | ===References=== |
Revision as of 18:50, 26 October 2020
GRHPR-his-tag
The enzyme efficiently catalyzes the reaction of reducing glyoxalic acid and consuming NADPH. His-tag was added to purify the protein. We use K880005 to construct the expression system and to express and to purify the protein.
Biology
GRHPR, a glyoxylate reductase from human liver, can reduce glyoxylic acid when NADPH is used as cofactor. GRHPR converts glyoxylic acid while consuming NADPH. NADPH is a suitable target compound that can be detected by the signal of fluorescence or OD340.[1]
- Fig 1. GRHPR mechanism
Usage
By codon optimization and adding a 6His-tag, the sequence suitable for expression in E. coli was constructed, and we hoped that it could reduce glyoxylic acid in E. coli to get fluorescence signal in the next processes we design.
The coding sequence of target gene was inserted into an expression vectors with BBa_K880005(BBa_J23100 & BBa_B0034) to obtain BBa_K3332056. We transformed the constructed plasmid into E. coli BL21 (DE3) to verify its successful heterologous expression.
- Fig 2. Gene circuit of GRHPR
Characterization
1. Identification After receiving the synthesized DNA, restriction digestion was done to certify that the plasmid was correct, and the experimental results were shown in figure 3. Fig 3.DNA gel electrophoresis of restriction digest products of GRHPR-His-pSB1C3 (Xbal I & Pst I sites)
2. Purification and Proof of the expression We used J23100 promoter to highly express GRHPR-Histag in E. coli in our composite part BBa_K3332056. Then, we used GE AKTA Prime Plus FPLC System to get purified GRHPR protein. We found an apparent protein peak in AKTA FPLC System and correct purified protein. Then, our target bands are observed through SDS-PAGE and the result is shown in figure4.
- Fig 4. SDS-PAGE of purification products of GRHPR-Histag-pSB1C3
3. Ability of consuming NADPH We mixed glyoxylic acid solution, NADPH solution and purified GRHPR protein dissolved in Tris-HCl(pH=7.5). Then, we immediately measured OD340 changes of our samples. And when NADPH is consumed, OD340 declines. The experimental result is shown on Figure 5. We can see the OD340 of samples adding GRHPR decrease very quickly while the OD340 of control stay almost the same.
- Fig 5. Enzyme activity of GRHPR
4. Kinetic parameter determination We successfully got OD340-Time curves of GRHPR in the presence of NADPH concentration and OD340-Time curves of GRHPR in the presence of glyoxylic acid concentration. Then we calculated relevant enzyme activity and drew 1/V-1/[NADPH] and 1/V-1/[glyoxylic acid] curves, from which we can obtain relevant Km and Vmax. The result is shown in figure 6 and figure 7.
- Fig 6. 1/V-1/[NADPH] curve of purified GRHPR reacting with NADPH and glyoxylic acid
- Fig 7. 1/V-1/[glyoxylic acid] curve of purified GRHPR reacting with NADPH and glyoxylic acid
References
- ↑ Rumsby G, Cregeen D P. Identification and expression of a cDNA for human hydroxypyruvate/glyoxylate reductase[J]. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1999, 1446(3): 383-388.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal AgeI site found at 547
- 1000COMPATIBLE WITH RFC[1000]